SLA 0.00% $3.34 silk laser australia limited

ropren concerns need to be addressed

  1. 580 Posts.
    At this point I'm willing to bet that a full Phase III trial will be required. There is just not enough data on the table to warrant approval at this time.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.